Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Benfida is a healthcare and wellness company that specializes in high-bioavailability nutritional supplements designed to support metabolic health and nerve function. The company's primary focus is on Benfotiamine, a fat-soluble derivative of Vitamin B1 (thiamine) that is more effectively absorbed by the body than standard thiamine. Benfida's products are specifically formulated to address complications associated with high blood sugar, such as diabetic neuropathy and oxidative stress. By providing pharmaceutical-grade supplements, the company aims to offer non-invasive options for managing metabolic disorders and improving long-term cellular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Benfida.